v3.26.1
Segment Disclosures (Details)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
USD ($)
segment
Mar. 31, 2025
USD ($)
Segment Disclosures    
Number of Reportable Segments | segment 1  
Total revenue $ 110 $ 868
Cost of product revenues 32 44
Depreciation and amortization expense $ 90 $ 83
Segment Reporting, Other Segment Item, Composition, Description Other segment expenses primarily include the gain on the sale of strategic investments as well as general and administrative costs not presented in other line items Other segment expenses primarily include the gain on the sale of strategic investments as well as general and administrative costs not presented in other line items
Interest expense (income), net $ 821 $ (166)
Net loss (20,691) (18,755)
Partnership revenue    
Segment Disclosures    
Total revenue   732
Product revenue    
Segment Disclosures    
Total revenue 110 136
Single Reportable Segment    
Segment Disclosures    
Cost of product revenues 32 44
Personnel and consulting costs 8,788 6,664
Stock-based compensation 2,851 2,965
Depreciation and amortization expense 90 83
Other segment expenses 595 2,626
Interest expense (income), net 821 (166)
Net loss (20,691) (18,755)
Single Reportable Segment | Partnership revenue    
Segment Disclosures    
Total revenue   732
Single Reportable Segment | Product revenue    
Segment Disclosures    
Total revenue 110 136
Single Reportable Segment | Non-clinical development costs    
Segment Disclosures    
Development costs 4,050 4,465
Single Reportable Segment | Clinical development costs    
Segment Disclosures    
Development costs $ 3,574 $ 2,942